210 related articles for article (PubMed ID: 18541682)
1. Nebivolol: a new antihypertensive agent.
Gray CL; Ndefo UA
Am J Health Syst Pharm; 2008 Jun; 65(12):1125-33. PubMed ID: 18541682
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
Del Sindaco D; Tinti MD; Monzo L; Pulignano G
Clin Interv Aging; 2010 Dec; 5():381-93. PubMed ID: 21152240
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol for the treatment of heart failure.
Dery AS; Hamilton LA; Starr JA
Am J Health Syst Pharm; 2011 May; 68(10):879-86. PubMed ID: 21546638
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol in the management of essential hypertension: a review.
McNeely W; Goa KL
Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
Moen MD; Wagstaff AJ
Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
Papademetriou V
Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
Kamp O; Metra M; Bugatti S; Bettari L; Dei Cas A; Petrini N; Dei Cas L
Drugs; 2010; 70(1):41-56. PubMed ID: 20030424
[TBL] [Abstract][Full Text] [Related]
9. [Pharma-clinics medication of the month. Nebivolol (Nobiten)].
Scheen AJ
Rev Med Liege; 2001 Nov; 56(11):788-91. PubMed ID: 11789394
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol: third-generation beta-blockade.
de Boer RA; Voors AA; van Veldhuisen DJ
Expert Opin Pharmacother; 2007 Jul; 8(10):1539-50. PubMed ID: 17661735
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
Agabiti Rosei E; Rizzoni D
Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
Van Bortel LM; Fici F; Mascagni F
Am J Cardiovasc Drugs; 2008; 8(1):35-44. PubMed ID: 18303936
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol: impact on cardiac and endothelial function and clinical utility.
Toblli JE; DiGennaro F; Giani JF; Dominici FP
Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
[TBL] [Abstract][Full Text] [Related]
14. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
15. [Nebivolol treatment in essential arterial hypertension].
Ghiuru R; Rezuş C; Ambăruş V; Ionescu S; Cosovanu A
Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):756-9. PubMed ID: 12092233
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol: a third-generation beta-adrenergic blocker.
Veverka A; Nuzum DS; Jolly JL
Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients.
Zanchetti A
Blood Press Suppl; 2004 Oct; 1():17-32. PubMed ID: 15587108
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol: in the treatment of hypertension in the US.
Baldwin CM; Keam SJ
Am J Cardiovasc Drugs; 2009; 9(4):253-60. PubMed ID: 19655820
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol: new therapy update.
Sule SS; Frishman W
Cardiol Rev; 2006; 14(5):259-64. PubMed ID: 16924166
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.
Patel RS; Sharma KH; Kamath NA; Patel NH; Thakkar AM
Indian J Pharmacol; 2014; 46(5):485-9. PubMed ID: 25298575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
